driven by the PitchBook Platform
Developer of vaccines and antibodies to treat bacterial infections. The company's products are based on a platform for identifying protein antigen targets that harness the immune system.
You’re viewing a free company profile from the PitchBook Platform. To explore Absynth Biologics’s full profile, request a free trial.
© 2017 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.